Dr. Charles Budinoff, Ph.D
Strain Discovery and Microbiome Science Group Leader| IFF Health and Biosciences
Dr. Charles Budinoff, Ph.D. is the Strain Discovery and Microbiome Science Group Leader at IFF Health. Charles is a part of the technology and innovation team driving research and development of new probiotics and therapeutics to improve human health and wellness. Prior to joining IFF Health, Charles directed R&D groups at Algenol Biotech, an algae product development and manufacturing company. His teams were responsible for engineering the microbiota within algal production systems to maximize performance. He also lead pilot plant operations for developing processes to extract and purify natural algal-based products for inclusion in foods and cosmetics. He has over 20 years of experience in microbial physiology, ecology, and genomics, with a special emphasis on understanding how different environments structure microbial diversity and how microbes influence overall system functioning. He has a master’s degree in Marine Science from the University of Georgia and a doctorate in Microbiology from the University of Tennessee.